Nakyung Jeon, BPharm, MPH

Nakyung Jeon

Contact Information



  • B.S. Pharmacy. College of Pharmacy, Ewha Womens’ University
    M.S. Graduate School of Public Health, Seoul National University


Entry Date into the POP PhD program:  Fall, 2013

Curriculum Vitae

Research Interests

  • Pharmacoepidemiology
  • Appropriate medication use in pediatric population
  • Medication safety (e.g. preventable adverse drug events)
  • Comparative effective research
  • Quality improvement


  • Grants
  • NIH R03 (PA-13-142), Title: Non-steroidal anti-inflammatory drugs-associated acute kidney injury among elderly
    Primary investigator : Almut G. Winterstein, PhD. Submitted (not funded)
  • 2nd Place Overall abstract, 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), Dublin, Ireland, Aug 2016
  • 2016 ICPE Scholarship, The International Society for Pharmacoepidemiology, May 2016
  • First Place, Oral presentation, UF College of Pharmacy 28th Annual Research Showcase, University of Florida, Florida, U.S., Feb 2011


  • Winterstein AG, Staley B, Henriksen C, Xu D, Lipori G, Jeon N et al. Development and validation of a Complexity-Score to rank hospitalized patients at risk for preventable adverse drug events. Am J Health Syst Pharm
  • Jeon N, Sorokina M, Henriksen C, Staley B, Lipori G, Winterstein AG. Measurement of clinically important preventable adverse drug events in hospital electronic health records – Development of the Drug Therapy Complexity Score Part 2. Am J Health Syst Pharm.
  • Jeon N, Staley B, Kenneth K, Winterstein AG. The Risk of Acute Kidney Injury of piperacillin-tazobactam plus vancomycin compared to cefepime plus vancomycin. Int J Antimicrob Agents
  • Jeon N, Staley B, Johnson T, Winterstein AG. Priortizing Preventable Adverse Drug Events for Pharmacist Intervention in Hospitals: Results of a Literature Review and an ASHP Member Survey. Am J Health Syst Pharm



  • Jeon N. Staley B, Henricksen C, Xu D, Lipori G, Brumback B, Winterstein AG. Development of risk model to predict drug induced acute kidney injury in hospitalized patients. 32nd Conference of Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, Pharmacoepi Drug Saf 2016; 25(Suppl. 3):269 (oral presentation), 2016
  • Jeon N, Winterstein AG. Addition of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Acute Kidney Injury (AKI) in Hospitalized Patients Receiving Vancomycin. 31st Conference of Pharmacoepidemiology & Therapeutic Risk Management, Boston, U.S. Pharmacoepi Drug Saf 2015;24:410-411 (oral presentation), 2015


Professional Affiliations

  • Member, International Society for Pharmacoepidemiology
  • Member, International Society for Pharmacoeconomics and Outcomes Research